Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1981 Feb;43(2):135–142. doi: 10.1038/bjc.1981.21

Angiotensin-converting enzyme and its association with outcome in lung cancer.

F K Rømer
PMCID: PMC2010507  PMID: 6258623

Abstract

Serum angiotensin-converting enzyme (SACE) in 141 patients with newly detected primary lung cincer was 22.1 +/- 6.1 nmol/ml/min (mean +/- s.d.); lower than in healthy controls (24.4 +/- 6.2 nmol/ml/min, P less than 0.02). No correlation was found between SACE and sex, age, site of cancer, histological type, or lung function. After subdivision of the patients according to increasing SACE levels: less than 16.0 (mean SACE of lung cancer--s.d.), 16.0-22.0, 22.1-28.2 and greater than 28.2 nmol/ml/min (mean SACE of lung cancer + s.d.) there was a strong association (P less than 0.001) between SACE level and the proportion of patients who were radically operated without relapse during 8-22 months follow-up. None of 23 patients within the lowest SACE range were cured, even though 7 were referred for operation after preoperative examination. In contrast, 10/25 patients (40%) within the highest SACE range were cured. The results suggest that low SACE is associated with poor prognosis in lung cancer, even in patients who are judged as being operable on preoperative evaluation; and measurement of preoperative SACE in lug cancer may be a useful prognostic indicator in this disorder.

Full text

PDF
135

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ashutosh K., Keighley J. F. Diagnostic value of serum angiotensin converting enzyme activity in lung diseases. Thorax. 1976 Oct;31(5):552–557. doi: 10.1136/thx.31.5.552. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bedrossian C. W., Woo J., Miller W. C., Cannon D. C. Decreased angiotensin-converting enzyme in the adult respiratory distress syndrome. Am J Clin Pathol. 1978 Aug;70(2):244–247. doi: 10.1093/ajcp/70.2.244. [DOI] [PubMed] [Google Scholar]
  3. Concannon J. P., Dalbow M. H., Hodgson S. E., Headings J. J., Markopoulos E., Mitchell J., Cushing W. J., Liebler G. A. Prognostic value of preoperative carcinoembryonic antigen (CEA) plasma levels in patients with bronchogenic carcinoma. Cancer. 1978 Sep;42(3 Suppl):1477–1483. doi: 10.1002/1097-0142(197809)42:3+<1477::aid-cncr2820420818>3.0.co;2-e. [DOI] [PubMed] [Google Scholar]
  4. Dent P. B., McCulloch P. B., Wesley-James O., MacLaren R., Muirhead W., Dunnett C. W. Measurement of carcinoembryonic antigen in patients with bronchogenic carcinoma. Cancer. 1978 Sep;42(3 Suppl):1484–1491. doi: 10.1002/1097-0142(197809)42:3+<1484::aid-cncr2820420819>3.0.co;2-j. [DOI] [PubMed] [Google Scholar]
  5. Laurberg P. Sarcoid reactions in pulmonary neoplasms. Scand J Respir Dis. 1975 May;56(1):20–27. [PubMed] [Google Scholar]
  6. Lieberman J. Elevation of serum angiotensin-converting-enzyme (ACE) level in sarcoidosis. Am J Med. 1975 Sep;59(3):365–372. doi: 10.1016/0002-9343(75)90395-2. [DOI] [PubMed] [Google Scholar]
  7. Lieberman J., Nosal A., Schlessner A., Sastre-Foken A. Serum angiotensin-converting enzyme for diagnosis and therapeutic evaluation of sarcoidosis. Am Rev Respir Dis. 1979 Aug;120(2):329–335. doi: 10.1164/arrd.1979.120.2.329. [DOI] [PubMed] [Google Scholar]
  8. Lieberman J. The specificity and nature of serum-angiotensin-converting enzyme (serum ACE) elevations in sarcoidosis. Ann N Y Acad Sci. 1976;278:488–497. doi: 10.1111/j.1749-6632.1976.tb47061.x. [DOI] [PubMed] [Google Scholar]
  9. Ryan J. W., Ryan U. S., Schultz D. R., Whitaker C., Chung A. Subcellular localization of pulmonary antiotensin-converting enzyme (kininase II). Biochem J. 1975 Feb;146(2):497–499. doi: 10.1042/bj1460497. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Rømer F. K. Angiotensin-converting enzyme in sarcoidosis. Acta Med Scand. 1979;206(1-2):27–30. doi: 10.1111/j.0954-6820.1979.tb13464.x. [DOI] [PubMed] [Google Scholar]
  11. Rømer F. K., Emmertsen K. Serum angiotensin-converting enzyme in malignant lymphomas, leukaemia and multiple myeloma. Br J Cancer. 1980 Aug;42(2):314–318. doi: 10.1038/bjc.1980.232. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Silverstein E., Friedland J., Kitt M., Lyons H. A. Increased serum angiotensin converting enzyme activity in sarcoidosis. Isr J Med Sci. 1977 Oct;13(10):995–1000. [PubMed] [Google Scholar]
  13. Silverstein E., Pertschuk L. P., Friedland J. Immunofluorescent localization of angiotensin converting enzyme in epithelioid and giant cells of sarcoidosis granulomas. Proc Natl Acad Sci U S A. 1979 Dec;76(12):6646–6648. doi: 10.1073/pnas.76.12.6646. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Soffer R. L. Angiotensin-converting enzyme and the regulation of vasoactive peptides. Annu Rev Biochem. 1976;45:73–94. doi: 10.1146/annurev.bi.45.070176.000445. [DOI] [PubMed] [Google Scholar]
  15. Stalcup S. A., Lipset J. S., Woan J. M., Leuenberger P., Mellins R. B. Inhibition of angiotensin converting enzyme activity in cultured endothelial cells by hypoxia. J Clin Invest. 1979 May;63(5):966–976. doi: 10.1172/JCI109397. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
  16. Turton C. W., Grundy E., Firth G., Mitchell D., Rigden B. G., Turner-Warwick M. Value of measuring serum angiotensin I converting enzyme and serum lysozyme in the management of sarcoidosis. Thorax. 1979 Feb;34(1):57–62. doi: 10.1136/thx.34.1.57. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES